Pandemic fluoroquinolone resistant <i>Escherichia coli</i> clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci.

Tchesnokova, Veronika; Radey, Matthew; Chattopadhyay, Sujay; Larson, Lydia; Weaver, Jamie Lee; Kisiela, Dagmara; Sokurenko, Evgeni V · Proc Natl Acad Sci U S A · 2019

basic_science · Level V

Where this comes from

Abstract

Global growth in antibiotic resistance is a major social problem. A high level of resistance to fluoroquinolones requires the concurrent presence of at least 3 mutations in the target proteins-2 in DNA gyrase (GyrA) and 1 in topoisomerase IV (ParC), which occur in a stepwise manner. In the <i>Escherichia coli</i> chromosome, the <i>gyrA</i> and <i>parC</i> loci are positioned about 1 Mb away from each other. Here we show that the 3 fluoroquinolone resistance mutations are tightly associated genetically in naturally occurring strains. In the latest pandemic uropathogenic and multidrug-resistant <i>E. coli</i> clonal group ST1193, the mutant variants of <i>gyrA</i> and <i>parC</i> were acquired not by a typical gradual, stepwise evolution but all at once. This happened as part of 11 simultaneous homologous recombination events involving 2 phylogenetically distant strains of <i>E. coli</i>, from an uropathogenic clonal complex ST14 and fluoroquinolone-resistant ST10. The gene exchanges swapped regions between 0.5 and 139 Kb in length (183 Kb total) spread along 976 Kb of chromosomal DNA around and between <i>gyrA</i> and <i>parC</i> loci. As a result, all 3 fluoroquinolone resistance mutations in GyrA and ParC have simultaneously appeared in ST1193. Based on molecular clock estimates, this potentially happened as recently as <12 y ago. Thus, naturally occurring homologous recombination events between 2 strains can involve numerous chromosomal gene locations simultaneously, resulting in the transfer of distant but tightly associated genetic mutations and emergence of a both highly pathogenic and antibiotic-resistant strain with a rapid global spread capability.

Medical subject headings